tiprankstipranks
Edwards Lifesciences Corp. (CH:EW)
NYSE:EW
Switzerland Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports

Edwards Lifesciences (EW) Financial Statements

2 Followers

Edwards Lifesciences Financial Overview

Edwards Lifesciences's market cap is currently CHF40.65B. The company's EPS TTM is CHF1.89; its P/E ratio is 46.30; Edwards Lifesciences is scheduled to report earnings on April 23, 2026, and the estimated EPS forecast is CHF0.59. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 6.07B$ 5.44B$ 5.01B$ 5.38B$ 5.23B
Gross Profit$ 4.74B$ 4.32B$ 3.97B$ 4.22B$ 4.01B
Operating Income$ 1.64B$ 1.38B$ 1.43B$ 1.70B$ 1.61B
EBITDA$ 1.43B$ 1.72B$ 1.53B$ 1.96B$ 1.89B
Net Income$ 1.07B$ 4.17B$ 1.40B$ 1.52B$ 1.50B
Balance Sheet
Cash & Short-Term Investments$ 4.23B$ 3.98B$ 1.63B$ 1.22B$ 1.47B
Total Assets$ 13.70B$ 13.06B$ 9.36B$ 8.29B$ 8.50B
Total Debt$ 705.40M$ 700.00M$ 685.10M$ 691.30M$ 690.30M
Net Debt$ -2.23B$ -2.35B$ -447.20M$ -77.70M$ -172.50M
Total Liabilities$ 3.36B$ 2.99B$ 2.64B$ 2.49B$ 2.67B
Stockholders' Equity$ 10.34B$ 10.00B$ 6.65B$ 5.81B$ 5.84B
Cash Flow
Free Cash Flow$ 1.33B$ 289.90M$ 629.50M$ 953.40M$ 1.40B
Operating Cash Flow$ 1.60B$ 542.30M$ 895.80M$ 1.22B$ 1.73B
Investing Cash Flow$ -712.90M$ 2.31B$ 173.80M$ 252.30M$ -1.72B
Financing Cash Flow$ -956.80M$ -983.00M$ -711.00M$ -1.58B$ -356.30M
Currency in USD

Edwards Lifesciences Earnings and Revenue History

Income Statement >

Edwards Lifesciences Debt to Assets

Balance Sheet >

Edwards Lifesciences Cash Flow

Cash Flow >

Edwards Lifesciences Forecast EPS vs Actual EPS

Earnings >